Hangzhou Tigermed Consulting Co., Ltd. is a leading provider of clinical research services for the pharmaceutical and biotechnology industry. Founded in 2004 and headquartered in Hangzhou, China, the company offers a comprehensive suite of services, including clinical trial management, biostatistics, data management, regulatory affairs, and medical translation. Tigermed plays a crucial role in the development of new drugs and therapies, ensuring that they meet regulatory standards and can be brought to market efficiently. With a strong presence not only in China but also in numerous international markets, Tigermed supports clients in navigating complex approval processes across multiple jurisdictions. Its expertise spans numerous therapeutic areas, providing tailored solutions that enhance the drug development process. Tigermed's contribution to the healthcare sector is significant as it accelerates the availability of cutting-edge treatments while maintaining safety and efficacy standards. It stands out in the financial market as a key player in the Contract Research Organization (CRO) industry, reflecting the growing demands for outsourced clinical research services.